iSTAR Medical’s glaucoma device MINIject shows positive one-year results in European trial

Growing body of evidence confirms MINIject is safe and effective with results sustained over time

Read more

Positive outcomes for iSTAR Medical’s MIGS MINIject shown in trials of over 130 glaucoma patients

Pooled data confirm excellent safety and efficacy profile with very low rate of reintervention

Read more

First truly biocompatible MIGS implant from iSTAR Medical shows consistently outstanding efficacy in patients with glaucoma

Two-year final results from STAR-I trial and initial data from STAR-II European trial tout MINIjectTM as a highly promising treatment.

Read more